McKesson Corporation (MCK) stock forecast · P/E 20, rev $403.43B
McKesson Corporation (MCK) is a medical distribution company listed on NYSE.
This MCK forecast page states what the cached financials imply — not a price target and not a guarantee. McKesson Corporation outlooks on Lician start from reported revenue and the latest filing, then you decide.
Latest reported MCK revenue for 2026-03-31 was $403.43B. Net income was $4.76B. Revenue was up 12.4% from 2025-03-31 to 2026-03-31. MCK currently screens at market cap $91.30B and trailing P/E 20.3.
The near-term path: Revenue was up 12.4% from 2025-03-31 to 2026-03-31. A forecast that ignores that change is just a story.
MCK currently screens at market cap $91.30B and trailing P/E 20.3. Stretching today's multiple into 2026 without a filing reason is how thin forecast pages get ignored.
When the next MCK 10-Q or 8-K lands, this outlook should move. Until then the SEC page is the source.
Not a prediction market. For the live quote and the full model, use the MCK stock page.
Not investment advice.